Sodium aescinate

七叶皂苷钠

Report date: 2026/03/21 20:00:21
NME

Base Information

Drug NameSodium aescinate
Drug Alias Name麦通纳
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionProstanoid FP receptor agonistsMelanocortin receptor 2 agonists
TargetsProstanoid FP receptorMelanocortin receptor 2
Therapy Area/IndicationsLow Back PainPainVenous Insufficiency +[7] 
Global Approved IndicationsBrain Edema
Approved Indications in ChinaBrain Edema
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLuye Pharma Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital of Air Force Medical UniversityWuhan Aimin Pharmaceutical FactoryJilin Jinsheng Pharmaceutical Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsLow Back PainPainVenous Insufficiency +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeV03
Related LinksN/A